The winding path from lab to patient

Despite potential short-cuts, drug development is a lengthy and risky process that culminates in marketing approval. However, just because a drug achieves regulatory approval, does not mean that it will be instantly available to those in need. The complex journey for a pharmaceutical to gain patient access continues.

The future(s) of healthcare?

Planning and financing healthcare is a challenging task for individuals, private insurance providers and governments. Public and private insurances must cater for a vast number of people ideally equally across all income classes. Indeed, increased healthcare spending can reduce inequalities in mortality between socioeconomic groups (Mackenbach, Hu et al. 2017). However, there can be an inherent conflict between the utility […]